News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Creative Biolabs Announced the Featured Technology Platform for Custom Antibody Engineering Services


5/28/2013 9:39:04 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

May 28, 2013 -- Creative Biolabs has developed and commercializes a full range of integrated innovative Bio-fishing services that are based on phage display technology. With extensive experience in construction of various phage display libraries, including cDNA, peptide and scFv/Fab antibody libraries, Creative Biolabs focuses on developing high specific, high affinity monoclonal antibodies for research, diagnostic and therapeutic use. Creative Biolabs also is professional in screening these libraries against protein, peptide, cells, special surfaces and chemicals. Affinity maturation based on sub-library construction and screening is readily available. Creative Biolabs has built up a series of peptide, human and mouse scFv/Fab phage display libraries that all have a great diversity. Creative Biolabs has a camelised human single domain antibody library constructed. Furthermore, bio-manufacturing of small antibodies in bacterial systems and production of full-size humanized IgG in gene-engineered CHO cells have brought its international recognition. The Bio-fishing platform enables rapid and effective discovery and efficient production of biological molecules that can provide opportunities for therapeutics, diagnostics and targeting agents.

“With the help of the featured platform, Creative Biolabs is more confident to offer customer better products and services”, the Chief Scientific officer of Creative Biolabs, Dr. Zhang said so.

For more information, visit http://www.creative-biolabs.com/phagedisplay.htm, or just call 1-631-871-5806 for your requirements or write an email to contact@creative-biolabs.com.



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES